LIVER TRANSPLANT RECIPIENTS
Clinical trials for LIVER TRANSPLANT RECIPIENTS explained in plain language.
Never miss a new study
Get alerted when new LIVER TRANSPLANT RECIPIENTS trials appear
Sign up with your email to follow new studies for LIVER TRANSPLANT RECIPIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can cutting immune drugs boost vaccine power in transplant patients?
Disease control CompletedThis study looked at 48 kidney and liver transplant recipients who had a weak antibody response after their initial COVID-19 vaccines. Researchers gave them an extra vaccine dose, and for some, they temporarily reduced the patients' immune-suppressing medications to see if that w…
Matched conditions: LIVER TRANSPLANT RECIPIENTS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
Liver transplant study seeks rejection warning signs
Knowledge-focused CompletedThis study looked at 221 liver transplant patients to see if a lab test could predict who might reject their new organ. Researchers analyzed gene patterns in the patients' blood to find early warning signs of rejection or acceptance. The goal was to better understand how the body…
Matched conditions: LIVER TRANSPLANT RECIPIENTS
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC